American Medical Systems Holdings Inc.
10700 Bren Road West
Minnetonka,
MN 55343
United States - Map
Phone: 952-930-6000
Fax: 952-930-6373
Web Site: http://www.americanmedicalsystems.com
| American Medical Systems Holdings, Inc. provides medical solutions to physicians treating men’s and women’s pelvic health conditions worldwide. It manufactures and markets surgical products to urologists, gynecologists, and urogynecologists for erectile restoration, benign prostatic hyperplasia, male urethral stricture, urinary and fecal incontinence, menorrhagia, and pelvic organ prolapse. The company’s products for men include AMS 700 MS, an inflatable prostheses; the InhibiZone antibiotic treatment to address the risk of surgical infections; Tactile Pump and Momentary Squeeze Pump; InVance and AdVance sling systems for the treatment of mild to moderate stress urinary incontinence; GreenLight HPS lasers and fibers for the treatment of obstructive benign prostatic hyperplasia; StoneLight laser and SureFlex fiber optics for the treatment of urinary stones; and UroLume endoprosthesis stents. Its women’s healthcare products comprise AMS 800 urinary control system; In-Fast, SPARC, Monarc, BioArc, and MiniArc systems that allow the surgeon to select the procedure appropriate to the patient’s symptoms and anatomy; InteXen LP, a lyophilized porcine dermis graft; Acticon neosphincter, an extension of the company’s urinary control technology; Apogee system designed to repair vaginal vault prolapse; Perigee system that targets repair of cystocele; and InteXen and IntePro pelvic reconstructive materials for use in traditional pelvic organ prolapse procedures. The company also offers Her Option cryoablation therapy products, which uses a microprocessor-controlled probe to eliminate excessive menstrual bleeding. American Medical Systems distributes its products through direct field representatives and independent distributors. The company was founded in 1972 and is headquartered in Minnetonka, Minnesota. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Mark A. Heggestad , 50
Chief Financial Officer, Principal Accounting Officer and Exec. VP |
$
312.00K | N/A | Mr. Ross A. Longhini , 47
Chief Operating Officer, Exec. VP and Member of Technology & Bus. Devel. Committee |
$
374.00K |
$
887.00K | Mr. Anthony Bihl III, 53
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Gil Otoo ,
Head of Engineering Aide of Reconstructive Materials Group |
N/A
| N/A | Mr. John F. Nealon , 46
Sr. VP and Gen. Mang. of Women's Health |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.16% Nasdaq 
Profile
